Implenia to acquire BAM Swiss AG to strengthen its healthcare buildings construction presence in Switzerland
With the agreed acquisition of BAM Swiss AG, Implenia becomes a leading construction services provider in the healthcare sector, strengthening market presence in Switzerland | Division Buildings expands capabili¬ties for complex large-scale projects | Employees of BAM Swiss AG planned to join Implenia | Implenia will ensure planning and realisation of Aarau Cantonal Hospital from a single source
Dietlikon, 30 March 2021 - The agreed acquisition of BAM Swiss AG strengthens Implenia's competitive position for upcoming tenders - especially for complex construction projects in the healthcare sector, but also in pharmaceuticals, transportation and logistics, as well as education and research. Implenia is expanding its market presence in the growth region around north-western Switzerland, in particular in and around the city of Basel.
At project level, Implenia will ensure the timely planning and realisation of the Cantonal Hospital Aarau from a single source - which has been done jointly with BAM Swiss AG and BAM Deutschland AG so far. In addition, with the acquisition of BAM Swiss AG Implenia's project portfolio will be enlarged by the BSSE project in Basel, a modern laboratory and research building for biosystems science and engineering as well as the project Felix Platter-Hospital in Basel and a student residence of the ETH in Zurich.
As a result of the acquisition - signed on 29 March 2021, anticipated to be closed on 31 May 2021 - 45 employees of BAM Swiss AG are planned to join Implenia. Implenia plans to take on responsibility for the ongoing projects after closing. Financial details of the transaction are not disclosed.
André Wyss, CEO Implenia: «With this transaction, Implenia strengthens its market presence and becomes a leading player in healthcare construction in Switzerland, which is a key driver in real estate with a large growth potential. The acquisition is in line with our strategy and the goal of Implenia's Buildings Division to increase its market share as a total contractor for complex large-scale projects. The Division's consulting unit will ensure early access to clients and collaborative involvement of all stakeholders in the pre-construction phase.»
Ruud Joosten, CEO Royal BAM Group: «With this transaction BAM is taking a step forward in line with our new strategy 'Building a sustainable tomorrow'. Our strategy is to focus on growth markets in the Netherlands, United Kingdom and Ireland, where we have scale and competitive advantage. In other markets we will manage our subsidiaries for value. With Implenia, we have identified a trusted partner who will support the future development of BAM Swiss AG.»
Contact for Investors and Analysts: Investor Relations, T +41 58 474 35 04, firstname.lastname@example.org
Investors' diary: 30 March 2021: Annual General Meeting 17 August 2021: Half-year Report 2021
As Switzerland's leading construction and real estate service provider, Implenia develops and builds homes, workplaces and infrastructure for future generations in Switzerland and Germany. It also plans and builds complex infrastructure projects in Austria, France, Sweden and Norway. Formed in 2006, the company can look back on around 150 years of construction tradition. The company brings together the know-how of its highly skilled consulting, planning and execution units under the umbrella of an integrated leading multinational construction and real estate service provider. With its broad offering and the extensive experience of its specialists, the Group can realise complex major projects and provide customer-centric support across the entire life-cycle of a building or structure. It focuses on customer needs and on striking a sustainable balance between commercial success and social and environmental responsibility. Implenia, with its headquarters in Opfikon near Zurich, employs more than 8,500 people across Europe and posted revenue of almost CHF 4 billion in 2020. The company is listed on the SIX Swiss Exchange (IMPN, CH0023868554). More information can be found at implenia.com.